Takeda Cambridge in Second Deal to Expand Use of Dimerix Bioscience’s GPCR-HIT Platform

PERTH, Australia--(BUSINESS WIRE)--Dimerix Bioscience Pty Ltd today announced that it has entered into a second research program with Takeda Cambridge Limited, a UK based subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. This new program is in addition to the continuing research program announced on 15 April 2010.

MORE ON THIS TOPIC